Skip to main content
. 2017 Jun 6;2017(6):CD012143. doi: 10.1002/14651858.CD012143.pub2
Trial name or title D‐Lite
Methods Randomised clinical trial
Participants 165 adults with chronic hepatitis C, genotype 1, HCV RNA > 100,000 IU/mL at screening, seronegative for HIV and Hepatitis B surface antigen, liver biopsy within prior 2 years; subjects with compensated cirrhosis can enrol and will be capped at approximately 10%
Interventions BMS‐790052 or BMS‐650032
Outcomes
Starting date 4 March 2011
Contact information
Notes NCT01309932